Opening Remarks by Sara Brenner, U.S. Food and Drug Administration
September 23, 2025
Similar Posts
Dr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025
Dr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025. Country: India. Record Type: 483Jewel Osco Stores in Illinois, Indiana and Iowa Voluntarily Recalls Select Items Containing Tuna Salad from Reser’s Fine Foods Due to an Ingredient Recall Linked to Possible Listeria Monocytogenes Contamination
Jewel Osco stores in Illinois, Indiana and Iowa are voluntarily recalling select items containing tuna salad supplied by Reser’s Fine Foods. This action follows a recall initiated by Reser’s Fine Food due to possible contamination with Listeria monocytogenes in breadcrumbs used as an ingredient in tInfusion Pump Correction: Baxter Updates Instructions for Use for Novum IQ Large Volume Pump due to Potential for Underinfusion
Infusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pump due to Potential for UnderinfusionVerified Clinical Benefit | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the specific indication.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has been in shortage since 2022 due to increased demand.Abbott Initiates Medical Device Correction for Certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S.
ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.